To CANCER IMMUNITY Home Page

Table 4

Patient characteristics.

Patient Code

HLA Class I Typing

NY-ESO-1 Status

mRNA

Ab

PC1

A*0207,*31;B*46,*56;Cw*01,*04

NDa

+

PC2

A*2601;B*4002,*35;Cw*0303,*0304

-b

+

PC3

A*0207,*2402;B*46,07*;Cw*01,*07

+

+

PC4

A*0201,*2402;B*4001,*52;Cw*0303,*1202

ND

-

aND, not determined.
bNY-ESO-1 mRNA expression was negative in the primary tumor, but was not determined in metastatic lymph nodes (see text).

 

Copyright © 2003 by Yuji Noguchi